These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 38268479)
1. The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder. Dever JA; Hertz MF; Dunlap LJ; Richardson JS; Wolicki SB; Biggers BB; Edlund MJ; Bohm MK; Turcios D; Jiang X; Zhou H; Evans ME; Guy GP Public Health Rep; 2024; 139(4):484-493. PubMed ID: 38268479 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey. Lee S; Sun L; Vakkalanka JP Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424 [TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. Wakeman SE; Larochelle MR; Ameli O; Chaisson CE; McPheeters JT; Crown WH; Azocar F; Sanghavi DM JAMA Netw Open; 2020 Feb; 3(2):e1920622. PubMed ID: 32022884 [TBL] [Abstract][Full Text] [Related]
4. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails. Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354 [TBL] [Abstract][Full Text] [Related]
5. Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit. Weiner SG; Little K; Yoo J; Flores DP; Hildebran C; Wright DA; Ritter GA; El Ibrahimi S JAMA Netw Open; 2024 Jul; 7(7):e2423954. PubMed ID: 39037812 [TBL] [Abstract][Full Text] [Related]
6. Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults. Jaffe K; Slat S; Chen L; Macleod C; Bohnert A; Lagisetty P J Subst Use Addict Treat; 2024 Aug; 163():209361. PubMed ID: 38703949 [TBL] [Abstract][Full Text] [Related]
7. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder. Bello JK; Xu KY; Salas J; Bedrick BS; Grucza RA J Gen Intern Med; 2024 Jun; 39(8):1342-1348. PubMed ID: 38424347 [TBL] [Abstract][Full Text] [Related]
9. Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder. Wang L; Volkow ND; Berger NA; Davis PB; Kaelber DC; Xu R J Clin Psychol; 2023 Dec; 79(12):2869-2883. PubMed ID: 37584532 [TBL] [Abstract][Full Text] [Related]
10. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation. Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540 [TBL] [Abstract][Full Text] [Related]
11. Barriers to retention in medications for opioid use disorder treatment in real-world practice. Villamil VI; Underwood N; Cremer LJ; Rooks-Peck CR; Jiang X; Guy GP J Subst Use Addict Treat; 2024 May; 160():209310. PubMed ID: 38331319 [TBL] [Abstract][Full Text] [Related]
12. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. Flanagan Balawajder E; Ducharme L; Taylor BG; Lamuda PA; Kolak M; Friedmann PD; Pollack HA; Schneider JA JAMA Netw Open; 2024 Sep; 7(9):e2434704. PubMed ID: 39316401 [TBL] [Abstract][Full Text] [Related]
13. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. Rogal S; Youk A; Agbalajobi O; Zhang H; Gellad W; Fine MJ; Belperio P; Morgan T; Good CB; Kraemer K Am J Gastroenterol; 2021 Jul; 116(7):1406-1413. PubMed ID: 33811202 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community. Biondi BE; Vander Wyk B; Schlossberg EF; Shaw A; Springer SA Addict Sci Clin Pract; 2022 Mar; 17(1):15. PubMed ID: 35255967 [TBL] [Abstract][Full Text] [Related]
15. Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People. Xu KY; Jones HE; Schiff DM; Martin CE; Kelly JC; Carter EB; Bierut LJ; Grucza RA Obstet Gynecol; 2023 Apr; 141(4):845-853. PubMed ID: 36897142 [TBL] [Abstract][Full Text] [Related]
16. The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections. Ivasiy R; Madden LM; DiDomizio E; Johnson KA; Machavariani E; Ahmad B; Oliveros D; Ram A; Kil N; Altice FL Drug Alcohol Depend; 2024 Oct; 263():112410. PubMed ID: 39159600 [TBL] [Abstract][Full Text] [Related]
17. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170 [TBL] [Abstract][Full Text] [Related]
18. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. Hadland SE; Bagley SM; Rodean J; Silverstein M; Levy S; Larochelle MR; Samet JH; Zima BT JAMA Pediatr; 2018 Nov; 172(11):1029-1037. PubMed ID: 30208470 [TBL] [Abstract][Full Text] [Related]
19. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities. Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922 [No Abstract] [Full Text] [Related]
20. Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults. Aleksanyan J; Choi S; Lincourt P; Burke C; Ramsey KS; Hussain S; Jordan AE; Morris M; D'Aunno T; Glied S; McNeely J; Elbel B; Mijanovich T; Adhikari S; Neighbors CJ PLoS One; 2024; 19(8):e0297567. PubMed ID: 39141672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]